{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:56:14Z","timestamp":1761918974704},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1007\/s11910-007-0039-x","type":"journal-article","created":{"date-parts":[[2007,5,8]],"date-time":"2007-05-08T05:41:27Z","timestamp":1178602887000},"page":"259-264","source":"Crossref","is-referenced-by-count":6,"title":["New directions in optic neuritis and multiple sclerosis"],"prefix":"10.1007","volume":"7","author":[{"given":"Molly E.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Sergott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,5,9]]},"reference":[{"key":"39_CR1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1212\/WNL.38.2.185","volume":"38","author":"J.F. Rizzo","year":"1988","unstructured":"Rizzo JF, Lessell S: Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology 1988, 38:185\u2013190.","journal-title":"Neurology"},{"key":"39_CR2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.45.2.244","volume":"45","author":"M. Rodirguez","year":"1995","unstructured":"Rodirguez M, Cross S: Optic neuritis: a population-based study in Olmsted County, MN. Neurology 1995, 45:244\u2013250.","journal-title":"Neurology"},{"key":"39_CR3","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","volume":"109","author":"The clinical profile of optic neuritis.","year":"1991","unstructured":"The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. Arch Ophthalmol 1991, 109:1673\u20131678.","journal-title":"Arch Ophthalmol"},{"key":"39_CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archopht.1993.01090020085029","volume":"111","author":"J. Keltner","year":"1993","unstructured":"Keltner J, Johnson C, Spurr J, et al.: Baseline visual field profile of optic neuritis: the experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1993, 111:231\u2013234.","journal-title":"Arch Ophthalmol"},{"key":"39_CR5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archopht.1993.01090060061023","volume":"111","author":"R.W. Beck","year":"1993","unstructured":"Beck RW, Cleary PA: Optic neuritis treatment trial: one-year follow up results. Arch Ophthalmol 1993, 111:773\u2013775.","journal-title":"Arch Ophthalmol"},{"key":"39_CR6","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","volume":"329","author":"R.W. Beck","year":"1993","unstructured":"Beck RW, Cleary PA, Trobe JD, et al.: The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 1993, 329:1764\u20131769.","journal-title":"N Engl J Med"},{"key":"39_CR7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0002-9394(03)00862-6","volume":"137","author":"R.W. Beck","year":"2004","unstructured":"Beck RW, Gal RL, Bhatti MT, et al.; Optic Neuritis Study Group: Visual function more than 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. Am J Ophthalmol 2004, 137:77\u201383.","journal-title":"Am J Ophthalmol"},{"key":"39_CR8","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1056\/NEJM199312093292411","volume":"329","author":"D.H. Silberberg","year":"1993","unstructured":"Silberberg DH: Corticosteroids and optic neuritis. N Engl J Med 1993, 329:1808\u20131810.","journal-title":"N Engl J Med"},{"key":"39_CR9","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","volume":"120","author":"F. Barkhof","year":"1997","unstructured":"Barkhof F, Filippi M, Miller DH: Comparison of MR imagning criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997, 120:2059\u20132069.","journal-title":"Brain"},{"key":"39_CR10","first-page":"702","volume":"21","author":"M. Tintore","year":"2000","unstructured":"Tintore M, Rovira A, Martinez M: Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol 2000, 21:702\u2013706.","journal-title":"Am J Neuroradiol"},{"key":"39_CR11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"W. McDonald","year":"2001","unstructured":"McDonald W, Compston A, Edan G: Recommended diagsnoitc criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121\u2013127.","journal-title":"Ann Neurol"},{"key":"39_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.10240","volume":"52","author":"C.M. Dalton","year":"2002","unstructured":"Dalton CM, Brex PA, Miszkiel KA, et al.: Application of the New McDonald Criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002, 52:47\u201353.","journal-title":"Ann Neurol"},{"key":"39_CR13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1474-4422(05)70071-5","volume":"4","author":"D. Miller","year":"2005","unstructured":"Miller D, Barkhof F, Montalban X, et al.: Clinically isolated syndromes suggestive of multiple sclerosis part I: natural history, pathogenesis, diagnosis and prognosis. Lancet Neurol 2005, 4:281\u2013288.","journal-title":"Lancet Neurol"},{"key":"39_CR14","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1002\/ana.410360704","volume":"36","author":"B. Weinshenker","year":"1994","unstructured":"Weinshenker B: Natural history of multiple sclerosis. Ann Neurol 1994, 36:S6\u2013S11.","journal-title":"Ann Neurol"},{"key":"39_CR15","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/brain\/awg081","volume":"126","author":"C. Confavreux","year":"2003","unstructured":"Confavreux C, Vukusic S, Adeleine P: Early clinical predictors and progression of irreversible disabitlity in multiple sclerosis: an amnestic process. Brain 2003, 126:770\u2013782.","journal-title":"Brain"},{"key":"39_CR16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ana.20363","volume":"57","author":"M. Tintore","year":"2005","unstructured":"Tintore M, Rovira A, Rio J, et al.: Is optic neuritis more benign than other first attacks in multiple sclerosis? Ann Neurol 2005, 57:210\u2013215.","journal-title":"Ann Neurol"},{"key":"39_CR17","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archneur.1993.00540080050013","volume":"50","author":"R.W. Beck","year":"1993","unstructured":"Beck RW, Arrington J, Murtagh FR, et al.: Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Neurol 1993, 50:841\u2013846.","journal-title":"Arch Neurol"},{"key":"39_CR18","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1001\/archneur.61.9.1386","volume":"61","author":"Optic Neuritis Study Group","year":"2004","unstructured":"Optic Neuritis Study Group: Long-term brain magnetic resonance imaging changes after optic neuritis in patients without clinically definite multiple sclerosis. Arch Neurol 2004, 61:1538\u20131541.","journal-title":"Arch Neurol"},{"issue":"Pt2","key":"39_CR19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/awg038","volume":"126","author":"M. Filippi","year":"2003","unstructured":"Filippi M, Bozzali M, Rovaris M, et al.: Evidence for widespread axonal damage at the earliest clnical stage of multiple sclerosis. Brain 2003, 126(Pt 2):433\u2013437.","journal-title":"Brain"},{"key":"39_CR20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","volume":"338","author":"B.D. Trapp","year":"1998","unstructured":"Trapp BD, Peterson J, Ransohoff RM, et al.: Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, 338:278\u2013285.","journal-title":"N Engl J Med"},{"key":"39_CR21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1468-1331.2004.00901.x","volume":"12","author":"A. Amirzagar","year":"2005","unstructured":"Amirzagar A, Tabasi A, Hkhosravi F, et al.: Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4-year follow up study. Eur J Neurol 2005, 12:25\u201330.","journal-title":"Eur J Neurol"},{"key":"39_CR22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1191\/1352458504ms1077oa","volume":"10","author":"A. Kheradvar","year":"2004","unstructured":"Kheradvar A, Tabasi A, Nikbin B, et al.: Influence of HLA on progression of optic neuritis to multiple sclerosis: results of a four year follow up study. Mult Scler 2004, 10:526\u2013531.","journal-title":"Mult Scler"},{"key":"39_CR23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jneuroim.2005.02.002","volume":"162","author":"H. Roed","year":"2005","unstructured":"Roed H, Frederiksen J, Langkilde A, et al.: Systemic T cell activation in acute clinically isolated optic neuritis. J Neuroimmunol 2005, 162:165\u2013172.","journal-title":"J Neuroimmunol"},{"key":"39_CR24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jneuroim.2005.02.010","volume":"163","author":"R. Hanne","year":"2005","unstructured":"Hanne R, Frederiksen J, Langkilde A, et al.: Systemic T-cell activation in acute clinically isolated optic neuritis. J Neuroimmunol 2005, 163:165\u2013172.","journal-title":"J Neuroimmunol"},{"key":"39_CR25","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/bjo.2003.040980","volume":"88","author":"T. Sorensen","year":"2004","unstructured":"Sorensen T, Roed H, Sellbjerg F. Optic neuritis: chemokine receptor CXCR3 and its ligangds. Br J Ophthalmol 2004, 88:1146\u20131148.","journal-title":"Br J Ophthalmol"},{"key":"39_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ana.20152","volume":"56","author":"K. Haubold","year":"2004","unstructured":"Haubold K, Owens GP, Kaur P, et al.: B-lymphocyte and plasma cell clonal expansion in monosymptomatic optic neuritis cerebrospinal fluid. Ann Neurol 2004, 56:97\u2013107.","journal-title":"Ann Neurol"},{"key":"39_CR27","first-page":"554","volume":"141","author":"M. Charcot","year":"1868","unstructured":"Charcot M: Histologie de las sclerose en plaques. Gaz Hosp 1868, 141:554\u2013555; 557\u2013558.","journal-title":"Gaz Hosp"},{"key":"39_CR28","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1212\/WNL.47.6.1469","volume":"47","author":"L. Truyen","year":"1996","unstructured":"Truyen L, van Waesberghe TH, Barkof F: Accumulation of hypointense lesions (\u201cblack holes\u201d) on T1 spin echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996, 47:1469\u20131476.","journal-title":"Neurology"},{"key":"39_CR29","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/WNL.50.5.1282","volume":"50","author":"M. Walderveen Van","year":"1998","unstructured":"Van Walderveen M, Kamphorst W, Scheltens P: Histopathologic correlate of hypointense lesions of T1 weighted spin-echo MRI in multiple sclerosis. Neurology 1998, 50:1282\u20131288.","journal-title":"Neurology"},{"key":"39_CR30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","volume":"326","author":"R.W. Beck","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM, et al.: A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 1992, 326:581\u2013588.","journal-title":"N Engl J Med"},{"key":"39_CR31","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0161-6420(95)30839-1","volume":"102","author":"R.T. Beck","year":"1995","unstructured":"Beck RT, Trobe JD: What we have learned from the Optic Neuritis Treatment Trial. Ophthalmology 1995, 102:1504\u20131508.","journal-title":"Ophthalmology"},{"key":"39_CR32","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","volume":"343","author":"L.D. Jacobs","year":"2000","unstructured":"Jacobs LD, Beck RW, Simon JH, et al.: Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. New Engl J Med 2000, 343:898\u2013904.","journal-title":"New Engl J Med"},{"key":"39_CR33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/1531-8249(199908)46:2<197::AID-ANA9>3.0.CO;2-P","volume":"46","author":"D.K. Li","year":"1999","unstructured":"Li DK, Party DW: Magnetic resonance imaging results of the PRISMS trial: a randomized, double blind, placebo-controlled study of interferon-beta 1a in relapsing-remitting multiple sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in Multiple Sclerosis. Ann Neurol 1999, 46:197\u2013206.","journal-title":"Ann Neurol"},{"key":"39_CR34","doi-asserted-by":"crossref","unstructured":"Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing\/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Lancet 1998, 352:1498\u20131504. Erratum in: Lancet 1999, 353:678.","DOI":"10.1016\/S0140-6736(98)03334-0"},{"key":"39_CR35","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1212\/01.WNL.0000034080.43681.DA","volume":"59","author":"H. Panitch","year":"2002","unstructured":"Panitch H, Goodin D, Francis G, et al.: Randomized, comparative study of interferon beta-1a treatment regimens in MS. Neurology 2002, 59:1496\u20131498.","journal-title":"Neurology"},{"key":"39_CR36","unstructured":"Kappos L: Betaseron in newly emerging multiple sclerosis initial treatment: clinical results. Paper presented at ECTRIMS\/ACTRIMS 2005. Thessaloniki, Greece; September 28 to October 1, 2005."},{"key":"39_CR37","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9394(02)02003-2","volume":"135","author":"A. Kanamori","year":"2003","unstructured":"Kanamori A, Nakamura M, Escano MF: Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography. Am J Ophthalmol 2003, 135:513\u2013520.","journal-title":"Am J Ophthalmol"},{"key":"39_CR38","first-page":"2520","volume":"40","author":"V. Parisi","year":"1999","unstructured":"Parisi V, Manni G, Spadaro M, et al.: Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 1999, 40:2520\u20132527.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"39_CR39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00006982-199414050-00010","volume":"14","author":"J. Kerrison","year":"1994","unstructured":"Kerrison J, Flynn T, Green W, et al.: Retinal pathologic changes in multiple sclerosis. Retina 1994, 14:445\u2013451.","journal-title":"Retina"},{"key":"39_CR40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.20575","volume":"58","author":"S.A. Trip","year":"2005","unstructured":"Trip SA, Schlottmann PG, Jones SJ, et al.: Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005, 58:383\u2013391.","journal-title":"Ann Neurol"},{"key":"39_CR41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0002-9394(14)71762-3","volume":"116","author":"A. Fercher","year":"1993","unstructured":"Fercher A, Hitzenberger C, Drexler W: In vivo optical coherence tomography. Am J Ophthalmol 1993, 116:113\u2013114.","journal-title":"Am J Ophthalmol"},{"key":"39_CR42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00055735-200212000-00006","volume":"13","author":"R. Foroozan","year":"2002","unstructured":"Foroozan R, Buono LM, Savino PJ, Segott RC: Acute demyelinating optic neuritis. Curr Opin Ophthalmol 2002, 13:375\u2013380.","journal-title":"Curr Opin Ophthalmol"},{"key":"39_CR43","unstructured":"Sergott RP, Etter E, Savino JP: In vivo neuroprotection with high-dose, high-frequency interferon therapy: a serial optical coherence tomography study in multiple sclerosis and optic neuritis. Paper presented at ECTRIMS\/ACTRIMS 2005. Thessaloniki, Greece; September 28 to October 1, 2005."}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-007-0039-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-007-0039-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-007-0039-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:24:37Z","timestamp":1559435077000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-007-0039-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["39"],"URL":"https:\/\/doi.org\/10.1007\/s11910-007-0039-x","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}